← Leaderboards
Akl C Fahed
Massachusetts General Hospital
$1,918,960
Attributed
$3,161,073
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$3,161,073 · 2
By mechanism
R01$2,484,226 · 1
K08$676,847 · 1
Top collaborators
- Michael Tse-Yin Lu3 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Pradeep Natarajan$19,143,655
- Guillermo J. Tearney$42,608,505
- Steven Kyle Grinspoon$75,757,679
- Ahmed A Tawakol$9,912,063
- Brett E Bouma$16,028,207
Others in their field
Other Rising Stars on “Risk Factors”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Gary Mays · Axle Informatics, Llc$50,929,860
- Anice Lowen · Emory University$9,438,846
- James Cappo · National Jewish Health$9,298,220
- Kari A Stephens · University Of Washington$9,270,394
- April Carson · University Of Mississippi Med Ctr$9,022,104
Research focus
Risk FactorsClinical PracticeParticipantCardiovascular SystemBiobankCardiovascular Risk FactorCoronary ArteriosclerosisMyocardial InfarctionVariantClinical RiskLifeGenomic MedicineAttenuatedAge RelatedAdoptionAfricanCholesterolClinical DataBlood GlucoseAsian AncestryAdherenceBlood PressureCareerCaregivers
Grant awards (7)
Coronary plaque changes with statin and colchicine among people with high polygenic risk- a mechanistic pilot study$832,994
R01 · FY2025 · HL · contact PI
Integrating genomic and nongenomic risk for coronary artery disease$169,560
K08 · FY2025 · HL · contact PI
Coronary plaque changes with statin and colchicine among people with high polygenic risk- a mechanistic pilot study$816,786
R01 · FY2024 · HL · contact PI
Integrating genomic and nongenomic risk for coronary artery disease$169,264
K08 · FY2024 · HL · contact PI
Coronary plaque changes with statin and colchicine among people with high polygenic risk- a mechanistic pilot study$834,446
R01 · FY2023 · HL · contact PI
Integrating genomic and nongenomic risk for coronary artery disease$169,098
K08 · FY2023 · HL · contact PI
Integrating genomic and nongenomic risk for coronary artery disease$168,925
K08 · FY2022 · HL · contact PI